NCT02689804View on ClinicalTrials.gov

EC PK in Women With Normal and Obese BMI

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 10, 2015

Primary Completion Date

December 29, 2015

Study Completion Date

February 3, 2017

Conditions
Contraception
Interventions
DRUG

LNG-EC

FDA-approved emergency contraceptive pill containing levonorgestrel 1.5mg

DRUG

UPA-EC

FDA-approved emergency contraceptive pill containing ulipristal acetate 30mg

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT02689804 - EC PK in Women With Normal and Obese BMI | Biotech Hunter | Biotech Hunter